 | ||||||
| discount deal | ||||||
| NEWS | ||||||
| The Takeda-Shire Deal: Potential Impact On Neuroscience The deal would combine the current leader in the ADHD market with a strong neuroscience pipeline. ... At the time of the offer, the deal was worth approximately $64 billion. ... I have yet to receive 2018 discount cards for my patients despite requests for this and significant use of them in previous years.
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment